In: Nursing
What grade does the USPSTF give HRT for osteoporosis?
The U.S. Preventive Services Task Force (USPSTF) assigns one of five letter grades (A, B, C, D, or I).
A - Strongly Recommended: The USPSTF strongly recommends that
clinicians provide [the service] to eligible patients. The USPSTF
found good evidence that [the service] improves important health
outcomes and concludes that benefits substantially outweigh
harms.
B - Recommended: The USPSTF recommends that clinicians provide [the
service] to eligible patients. The USPSTF found at least fair
evidence that [the service] improves important health outcomes and
concludes that benefits outweigh harms.
C - No Recommendation: The USPSTF makes no recommendation for or
against routine provision of [the service]. The USPSTF found at
least fair evidence that [the service] can improve health outcomes
but concludes that the balance of benefits and harms is too close
to justify a general recommendation.
D - Not Recommended: The USPSTF recommends against routinely
providing [the service] to asymptomatic patients. The USPSTF found
at least fair evidence that [the service] is ineffective or that
harms outweigh benefits.
I - Insufficient Evidence to Make a Recommendation:The USPSTF
concludes that the evidence is insufficient to recommend for or
against routinely providing [the service]. Evidence that the
[service] is effective is lacking, of poor quality, or conflicting
and the balance of benefits and harms cannot be determined.
The USPSTF has given HRT for osteoporosis as grade D. The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women.